arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Alto Neuroscience, Inc.

ANRO

$28.66 ▲ +0.19 (+0.67%) at close

14 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Alto Neuroscience, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $942.7M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -8.3% ↘

FCF / Share $-0.84

Trailing P/E —

Price / Book 4.1x

FCF Yield —

Debt / Equity 0.06

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-26.24M

↓ -73.0% —

FCF / Share Free cash flow per share

$-0.84

↓ -37.1% —

Long-Term Debt Long-term obligations

$13.88M

↓ -14.1% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health →

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
EPS Growth YoY (%)	-42.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	19.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	16.1% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	-8.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	26.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	81.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	74.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	74.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	61.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-73.0% Weak ↓ Weak Declining Year-over-year change in net income	-6.5% Weak ↑ Weak Improving Year-over-year change in net income	-13.1% Weak ↑ Weak Improving Year-over-year change in net income	-13.1% Weak ↑ Weak Improving Year-over-year change in net income	-13.1% Weak ↑ Weak Improving Year-over-year change in net income	-35.5% Weak ↑ Weak Improving Year-over-year change in net income	-84.2% Weak → Weak Stable Year-over-year change in net income	-84.2% Weak Weak Year-over-year change in net income	-84.2% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-37.1% Weak Weak Year-over-year change in free cash flow	—	—	—	3.7% Caution Caution Year-over-year change in free cash flow	—	—	—	68.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
FCF / Net Income (x)	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-8.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	13.7% Good Good Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-13.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-10.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-10.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-13.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-12.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-10.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-10.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-8.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-7.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-6.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	15.7% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	11.9% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-21%)	13.8% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	16.1% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+7%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	0.06x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	0.11x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	0.18x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	0.16x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-73%)	0.14x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-76%)	0.07x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	-0.14x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-123%)	—	—	—	—
Interest Coverage (x)	-79.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-40.13x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-32.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-40.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-50.41x Weak Weak Operating income divided by interest expense Optimal: > 5x	-68.54x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-58.01x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-47.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-39.50x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-38.67x Weak Weak Operating income divided by interest expense Optimal: > 5x	-39.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-249.88M	$-160.31M	$-117.50M	$-127.46M	$-140.81M	$-157.97M	$-171.54M	$-183.06M	$-195.94M	$-72.69M	—	—	—	—
Debt / EBITDA (x)	-0.52x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.96x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.38x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.08x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.29x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.61x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.54x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.55x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.70x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.85x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Basic EPS, GAAP (USD)	$-0.80	$-0.45	$-0.52	$-0.65	$-0.56	$-0.56	$-0.62	$-0.60	$-0.76	$-2.98	$-2.44	$-2.33	$-1.97	—
Free Cash Flow per Share (USD)	$-0.84	—	$-0.37	$-0.51	$-0.61	—	—	—	$-0.64	—	$-2.09	$-1.80	$-2.04	—
Book Value per Share (USD)	$6.94	$4.73	$4.11	$4.56	$5.14	$5.61	$6.12	$6.67	$7.18	$-18.70	$-16.33	$-14.15	$-12.25	—
Tangible Book Value per Share (USD)	$6.94	$4.73	$4.11	$4.56	$5.14	$5.61	$6.12	$6.67	$7.18	$-18.70	$-16.33	$-14.15	$-12.25	—
Basic Weighted Avg Shares (shares)	32.89M	—	27.10M	27.07M	27.05M	—	26.96M	26.91M	17.60M	—	3.74M	3.72M	3.69M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$256.01M	$166.39M	$130.40M	$141.72M	$156.27M	$159.33M	$169.51M	$185.57M	$200.30M	$79.78M	—	—	—	—
LT Debt (USD)	$13.88M	$16.17M	$20.31M	$20.12M	$19.94M	$10.25M	$10.16M	$10.06M	$9.96M	$9.86M	—	—	—	—
Total Equity (USD)	$243.37M	$151.14M	$111.56M	$123.41M	$139.10M	$151.46M	$165.05M	$179.78M	$193.10M	$-71.67M	$-61.10M	$-52.60M	$-45.23M	$-38.41M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Depreciation Expense (USD)	$184.00K	$157.00K	$200.00K	$100.00K	$171.00K	$170.00K	$200.00K	$100.00K	$97.00K	$112.00K	$100.00K	$100.00K	$86.00K	—
Net Income, GAAP (USD)	$-26.24M	$-16.18M	$-15.17M	$-15.17M	$-15.17M	$-15.20M	$-13.42M	$-13.42M	$-13.42M	$-11.22M	$-7.28M	$-7.28M	$-7.28M	—
Operating Cash Flow (USD)	$-27.09M	$-11.52M	$-9.92M	$-13.78M	$-16.56M	$-13.02M	—	—	$-10.98M	$-11.52M	$-7.76M	$-6.63M	$-7.52M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 14 quarters

Alto Neuroscience, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ANRO with peers